retatrutide phase 2 weight loss Survodutide vs. for Triple hormone receptor agonist retatrutide

Blood tests, clinician reviews, side-effect support, and repeat monitoring are the things that protect you

Ethical Considerations This study (ICREC#7363051) was reviewed by the Imperial College Research Ethics Committee, which granted a favorable opinion, signifying that the Committee determined the study to be ethically acceptable and in alignment with institutional and regulatory guidelines

Rotation protocol Rotate injection sites every week

It remains experimental and is not FDA-approved as a therapy

Rotate between sites with each injection to prevent skin or fat damage

But GLP-1 agonists also come with side effects, mostly gastrointestinal, including constipation, nausea, and diarrhea